Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuanhao Tang

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 16, 2015
[Sequential Treatment of Advanced Squamous Lung Cancer: 
First-line Gemcitabine +/- platinum Followed by Second-line Taxanes +/- platinum Versus Reverse Sequence]Jing Xu, Xiaoqing Liu, Hongjun Gao, et al.
Gene|November 4, 2015
Over-expressed RPL34 promotes malignant proliferation of non-small cell lung cancer cellsShaoxing Yang, Jian Cui, Yingshun Yang, et al.
Disease Markers|April 8, 2017
The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass SpectrometryJing Xu, Bin Xu, Chuanhao Tang, et al.
Plos One|November 22, 2013
Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancerXiaohong Tan, Julian Carretero, Zhao Chen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 10, 2020
Establishment and validation of a novel droplet digital PCR assay for ultrasensitive detection and dynamic monitoring of EGFR mutations in peripheral blood samples of non-small-cell lung cancer patientsChuanhao Tang, Lingxiang Zhu, Lijuan Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 15, 2016
Enhanced and Differential Capture of Circulating Tumor Cells from Lung Cancer Patients by Microfluidic Assays Using Aptamer CocktailLibo Zhao, Chuanhao Tang, Li Xu, et al.
Biosensors & Bioelectronics|September 14, 2024
Microdroplet-enhanced chip platform for high-throughput immunotherapy marker screening from extracellular vesicle RNAs and membrane proteinsChuanhao Tang, Zaizai Dong, Shi Yan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 24, 2013
Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patientsChuanhao Tang, Yi Liu, Haifeng Qin, et al.
Journal for Immunotherapy of Cancer|December 1, 2023
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitinationZhijia Sun, Haixing Mai, Chunyuan Xue, et al.
Oncotarget|May 13, 2017
Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancerLili Qu, Liangliang Li, Xiaofei Zheng, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 16, 2015
[Sequential Treatment of Advanced Squamous Lung Cancer: 
First-line Gemcitabine +/- platinum Followed by Second-line Taxanes +/- platinum Versus Reverse Sequence]Jing Xu, Xiaoqing Liu, Hongjun Gao, et al.
Gene|November 4, 2015
Over-expressed RPL34 promotes malignant proliferation of non-small cell lung cancer cellsShaoxing Yang, Jian Cui, Yingshun Yang, et al.
Disease Markers|April 8, 2017
The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass SpectrometryJing Xu, Bin Xu, Chuanhao Tang, et al.
Plos One|November 22, 2013
Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancerXiaohong Tan, Julian Carretero, Zhao Chen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 10, 2020
Establishment and validation of a novel droplet digital PCR assay for ultrasensitive detection and dynamic monitoring of EGFR mutations in peripheral blood samples of non-small-cell lung cancer patientsChuanhao Tang, Lingxiang Zhu, Lijuan Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 15, 2016
Enhanced and Differential Capture of Circulating Tumor Cells from Lung Cancer Patients by Microfluidic Assays Using Aptamer CocktailLibo Zhao, Chuanhao Tang, Li Xu, et al.
Biosensors & Bioelectronics|September 14, 2024
Microdroplet-enhanced chip platform for high-throughput immunotherapy marker screening from extracellular vesicle RNAs and membrane proteinsChuanhao Tang, Zaizai Dong, Shi Yan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 24, 2013
Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patientsChuanhao Tang, Yi Liu, Haifeng Qin, et al.
Journal for Immunotherapy of Cancer|December 1, 2023
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitinationZhijia Sun, Haixing Mai, Chunyuan Xue, et al.
Oncotarget|May 13, 2017
Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancerLili Qu, Liangliang Li, Xiaofei Zheng, et al.
Pageof 7